Literature DB >> 12046044

Prevalence of constipation in continuous ambulatory peritoneal dialysis patients and comparison with hemodialysis patients.

Gen Yasuda1, Kazuhiko Shibata, Toshikazu Takizawa, Yumiko Ikeda, Yasuo Tokita, Satoshi Umemura, Osamu Tochikubo.   

Abstract

Many hemodialysis patients suffer from constipation. The frequency of constipation has not been rigorously evaluated in continuous ambulatory peritoneal dialysis (CAPD) patients, however. We conducted a survey on constipation in CAPD patients and compared the findings with those in hemodialysis patients through a questionnaire. Daily dietary fiber and potassium intake were calculated from the patients' dietary records. In the questionnaire, patients were asked about bowel frequency, stool consistency, straining, and use of laxatives and resins. The frequency of constipation was 28.9% in 204 CAPD patients and 63.1% in 268 hemodialysis patients. The hemodialysis patients had a 3.14 times higher relative risk of constipation than the CAPD patients. Only 3.4% of CAPD patients needed resin to avoid hyperkalemia. Of hemodialysis patients, 49% needed resin. Among the 261 hemodialysis patients, 205 (78.5%) suppressed an urge to defecate during hemodialysis therapy. Potassium and total dietary fiber intake per day were 1.8 +/- 0.5 g and 11.0 +/- 4.0 g in CAPD patients, which were higher (P < 0.01) than the values in hemodialysis patients--1.3 +/- 0.5 g and 5.9 +/- 2.7 g. The results suggest that constipation occurs less frequently in CAPD patients than in hemodialysis patients. The low rate of constipating drug administration, dialysis modality-based lifestyle, and higher total dietary fiber intake may cause the lower prevalence of constipation in CAPD patients. Copyright 2002 by the National Kidney Foundation, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12046044     DOI: 10.1053/ajkd.2002.33407

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  27 in total

1.  Acute appendicitis in patients with end-stage renal disease.

Authors:  Pei-Wen Chao; Shuo-Ming Ou; Yung-Tai Chen; Yi-Jung Lee; Feng-Ming Wang; Chia-Jen Liu; Wu-Chang Yang; Tzeng-Ji Chen; Tzen-Wen Chen; Szu-Yuan Li
Journal:  J Gastrointest Surg       Date:  2012-07-10       Impact factor: 3.452

2.  Effect of Tenapanor on Serum Phosphate in Patients Receiving Hemodialysis.

Authors:  Geoffrey A Block; David P Rosenbaum; Maria Leonsson-Zachrisson; Magnus Åstrand; Susanne Johansson; Mikael Knutsson; Anna Maria Langkilde; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2017-02-03       Impact factor: 10.121

Review 3.  The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.

Authors:  David Briskey; Patrick Tucker; David W Johnson; Jeff S Coombes
Journal:  Clin Exp Nephrol       Date:  2016-03-10       Impact factor: 2.801

4.  Clinical factors associated with constipation in hemodialysis patients.

Authors:  Ryota Ikee; Takayuki Toyoyama; Toko Endo; Masataka Tsunoda; Nobuo Hashimoto
Journal:  Int Urol Nephrol       Date:  2016-07-05       Impact factor: 2.370

5.  The Safety of Eplerenone in Hemodialysis Patients: A Noninferiority Randomized Controlled Trial.

Authors:  Michael Walsh; Braden Manns; Amit X Garg; Joe Bueti; Christian Rabbat; Andrew Smyth; Jessica Tyrwhitt; Jackie Bosch; Peggy Gao; P J Devereaux; Ron Wald
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-02       Impact factor: 8.237

6.  Effects of Fructo-Oligosaccharide Supplementation on Constipation in Elderly Continuous Ambulatory Peritoneal Dialysis Patients.

Authors:  Kulwara Meksawan; Chorsakon Chaotrakul; Napat Leeaphorn; Suthep Gonlchanvit; Somchai Eiam-Ong; Talerngsak Kanjanabuch
Journal:  Perit Dial Int       Date:  2014-10-07       Impact factor: 1.756

Review 7.  Gastrointestinal disorders and renal failure: exploring the connection.

Authors:  Shayan Shirazian; Jai Radhakrishnan
Journal:  Nat Rev Nephrol       Date:  2010-07-06       Impact factor: 28.314

8.  The Relationship between Serum Oxalic Acid, Central Hemodynamic Parameters and Colonization by Oxalobacter formigenes in Hemodialysis Patients.

Authors:  Baris Gulhan; Kultigin Turkmen; Merve Aydin; Murat Gunay; Aytekin Cıkman; Murat Kara
Journal:  Cardiorenal Med       Date:  2015-04-17       Impact factor: 2.041

9.  MgCaCO3 versus CaCO3 in peritoneal dialysis patients--a cross-over pilot trial.

Authors:  Baigalmaa Evsanaa; Irene Liu; Babak Aliazardeh; Sara Mahdavi; Gursarn Bajwa; Jerry Gula; Michelle Tam; Elena Sze; Janet M Roscoe; Paul Y Tam; Tabo Sikaneta
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

10.  Gastrointestinal symptoms: a comparison between patients undergoing peritoneal dialysis and hemodialysis.

Authors:  Rui Dong; Zhi-Yong Guo; Jia-Rong Ding; Yang-Yang Zhou; Hao Wu
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.